FDA’s device center wants to better leverage "big data," evidence from clinical experience, and patient-reported outcome measures, among other goals, to assist in regulatory decision making, the division’s Center Science Council says in an Oct. 20 document
listing the center’s top 10 science priorities for fiscal-year 2016.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?